CEO FLUIDDA now Member of advisory board Respiratory Innovation Summit (RIS)

Jan de Backer, MSc,PhD,MBA. CEO of FLUIDDA recently became member of the advisory board of the RIS.

The Respiratory Innovation Summit unites the innovators, investors and clinicians who are leading the fight to create powerful new treatments for deadly and crippling diseases of the lungs and airways.

Here you can find more information about the RIS advisory board.

Sorry, comments are closed for this post.